GELS

+ Watchlist + Portfolio

Gelteq Limited

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.55
52-Week Range: $0.39 – $2.02
Market Cap: $5.97M
P/E (TTM): —
EPS (TTM): -0.52
Dividend Yield: —

Advanced Metrics

Price/Book: 0.62
PEG Ratio: —
Return on Equity: -42.93%
Return on Assets: -17.61%
Gross Margin: 75.54%
Operating Margin: -1985.28%
Profit Margin: 0.00%
Current Ratio: 0.09
Debt/Equity: 0.36
Total Debt: $5.11M
Free Cash Flow: $-4.75M
Revenue Growth: 48.90%
Earnings Growth: —
Enterprise Value: $11.32M

GELS Income statement, annual periods, in AUD
AUD	FY2022	FY2023	FY2024	FY2025
Revenue	$147.54K	$79.84K	$0.00	$165.65K
Cost of Revenue	$94.87K	$48.92K	$0.00	—
Gross Profit	$52.66K	$30.92K	$0.00	—
Research & Development	$529.02K	$665.03K	$276.06K	$628.61K
Selling, General & Admin	$1.43M	$1.53M	$1.09M	$2.22M
Operating Expenses	$3.25M	$3.41M	$2.61M	$5.12M
Operating Income	-$3.19M	-$3.38M	-$2.61M	-$4.95M
EBITDA	-$1.98M	-$1.88M	-$1.75M	-$3.53M
Pretax Income	-$3.37M	-$3.51M	-$3.55M	-$6.65M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$3.37M	-$3.51M	-$3.55M	-$6.65M
Diluted EPS	-0.36	-0.37	-0.38	-0.72
Diluted Shares	9.44M	9.44M	9.44M	9.27M

GELS Balance Sheet statement, annual periods, in AUD
AUD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$162.49K	$399.22K	$24.52K	$344.65K
Receivables	$250.67K	$345.29K	$183.00K	$459.72K
Inventory	$95.20K	$95.20K	$0.00	—
Current Assets	$720.07K	$990.97K	$303.23K	$1.51M
Total Assets	$23.41M	$22.49M	$20.76M	$21.48M
Current Liabilities	$1.08M	$1.36M	$3.87M	$5.63M
Long-Term Debt	$1.46M	$2.47M	$1.76M	$13.55K
Total Debt	$1.51M	$2.49M	$3.84M	$4.22M
Total Liabilities	$2.55M	$3.84M	$5.65M	$5.67M
Retained Earnings	-$4.48M	-$7.95M	-$11.50M	-$18.14M
Shareholders' Equity	$20.86M	$18.66M	$15.11M	$15.80M
Working Capital	-$360.89K	-$373.55K	-$3.56M	-$4.13M
Net Debt	$1.30M	$2.08M	$3.82M	$3.87M

GELS Cash Flow statement, annual periods, in AUD
AUD	FY2022	FY2023	FY2024	FY2025
Capital Expenditure	—	-$75.93K	-$148.17K	-$642.23K
Free Cash Flow	-$1.51M	-$1.85M	-$1.22M	-$6.16M
Investing Cash Flow	$0.00	-$75.93K	-$148.17K	-$736.84K
Financing Cash Flow	$1.49M	$2.03M	$843.94K	$6.45M
Net Change in Cash	-$20.20K	$184.18K	-$374.70K	$195.06K

GELS Balance Sheet statement, quarterly periods, in AUD
AUD	Q4 2024	Q2 2025	Q4 2025
Cash & Equivalents	$3.05M	$344.65K	$9.35K
Receivables	$305.01K	$459.72K	$414.78K
Current Assets	$4.94M	$1.51M	$533.08K
Total Assets	$25.12M	$21.48M	$20.13M
Current Liabilities	$6.28M	$5.63M	$5.87M
Long-Term Debt	$13.55K	$13.55K	$13.55K
Total Debt	$3.90M	$4.22M	$5.11M
Total Liabilities	$6.32M	$5.67M	$5.92M
Retained Earnings	-$14.80M	-$18.14M	-$21.88M
Shareholders' Equity	$18.79M	$15.80M	$14.20M
Working Capital	-$1.34M	-$4.13M	-$5.34M
Net Debt	$849.73K	$3.87M	$5.10M

Market Snapshot

About

Gelteq Limited is a specialty materials company focused on developing and commercializing gelatin-based technologies and products. The company manufactures gelatin capsules, pharmaceutical excipients, and gelatin-based solutions for the pharmaceutical, nutraceutical, and food industries. Gelteq's operations include production facilities and research capabilities aimed at serving the growing demand for plant-based and specialty gelatin alternatives. The company targets markets in pharmaceuticals, dietary supplements, and functional foods.